ROIV – roivant sciences ltd. (US:NASDAQ)
Stock Stats
News
Institutional investors are Roivant Sciences Ltd.'s (NASDAQ:ROIV) biggest bettors and were rewarded after last week's US$290m market cap gain [Yahoo! Finance]
Dermavant Announces FDA Acceptance of Supplemental New Drug Application (sNDA) for VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older [Yahoo! Finance]
Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis
Roivant Sciences: Cashing In On Vants And Ventures [Seeking Alpha]
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market [Yahoo! Finance]
Form 4 Roivant Sciences Ltd. For: Apr 28 Filed by: Pulik Richard
Form 4 Roivant Sciences Ltd. For: Apr 24 Filed by: Fitzgerald Meghan
Form 4 Roivant Sciences Ltd. For: Apr 24 Filed by: Oren Ilan
Form 4 Roivant Sciences Ltd. For: Apr 24 Filed by: MOMTAZEE JAMES C
Form 4 Roivant Sciences Ltd. For: Apr 24 Filed by: Epperly Melissa B,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.